[ad_1]
A case of a serious allergic reaction was reported to a healthcare worker who was given the Pfizer vaccine for Covid-19 at Bartlett Regional Hospital in Juneau, Alaska.
Serious allergic reaction to the Pfizer vaccine
What happened? The woman, a middle-aged American health worker, developed a severe allergic reaction, but her condition is now stable, according to the report. “New York Times”, citing health sources. The subject had no history of allergies, but still developed a severe allergic reaction 10 minutes after the vaccine was administered. The woman received the first dose of the vaccine from Pfizer and Biontech in front of the cameras on December 11 as part of the government’s campaign to promote “confidence in vaccines” among US citizens.
She had skin rashes, tachycardia, and a respiratory crisis, so she was given epinephrine. But the symptoms returned and forced the doctors to use steroids as well. A further aggravation forced an emergency hospitalization in the intensive care unit. The woman recovered and is now fine. The woman who has had the most severe reaction remains under medical surveillance after her medical condition stabilizes.
Pfizer said it is investigating what happened with local authorities: it does not yet have all the detailed information. In addition, a second employee, vaccinated yesterday, presented allergic symptoms, but recovered quickly. Two similar cases have occurred in Great Britain. The issue of possible adverse reactions to the new vaccine is once again important.
Although the Pfizer vaccine has been shown to be 95% safe and effective in a clinical study involving 44,000 participants, the Alaskan cases are likely to heighten concerns about potential side effects beyond the US. Experts They said the developments could lead to the need for stricter guidelines to ensure that those vaccinated are closely monitored for adverse reactions. Millions of Americans are expected to be vaccinated with the Pfizer vaccine by the end of the year.
Alaska health authorities have announced that vaccine distribution plans will not change.
When the Pfizer vaccine arrives in Italy
The vaccination campaign against Covid-19 in Italy will begin with the first 1,833,975 doses that will be distributed by Pfizer-BioNTech. With the approval of Ema, the European drug agency, the vaccine will be commercialized in the session of December 21 and after the subsequent, almost immediate validation of the AIFA, the European “Vaccine Day” will be celebrated before the end of the year , in which the first citizens will be vaccinated the same day, as agreed between the Health Ministers of Belgium, France, Germany, Italy, Luxembourg, Holland, Spain and Switzerland.
In the coming days, instead, the first mass vaccination session will be launched, aimed at the categories that the government and Parliament have established as priorities: health and socio-health workers, personnel who operate in hospitals, public and private, guests and staff of residences for the elderly.
The State-Regions Conference shared the breakdown of the first doses that will initially be sent to the Regions: 304,955 will go to Lombardy, 183,138 to Emilia Romagna, 179,818 to Lazio, followed by Piedmont (with 170,995), Veneto (with 164,278) and Campania (135,890). The second supply guaranteed by Pfizer There will be 2,507,700 doses, which will allow the second dose to be administered to the same priority categories in the coming weeks and to initiate vaccination of the most fragile population.
